Safety and efficacy of alectinib versus crizotinib in alk-positive non-small cell lung cancer: An update meta-analysis

Rui Xiong; Haitan Fu; Qianrui Zhang; Wei Li

doi:10.36721/PJPS.2023.36.2.REG.365-372.1

original articles

Safety and efficacy of alectinib versus crizotinib in alk-positive non-small cell lung cancer: An update meta-analysis

Rui Xiong, Haitan Fu, Qianrui Zhang, Wei Li

Vol. 36

Issue 2

Pages 365-372

Published 01 Mar 2023

DOI: 10.36721/PJPS.2023.36.2.REG.365-372.1

Authors Abstract Related

Authors & Affiliations

Rui Xiong

Haitan Fu

Qianrui Zhang

Wei Li

Abstract

Our study aimed to evaluate the efficacy and toxicity of alectinib compared with crizotinib and provide

Keywords

Alectinib

Crizotinib

NSCLC

Meta-analysis

Metrics

PlumX Metrics

original articles

Safety and efficacy of alectinib versus crizotinib in alk-positive non-small cell lung cancer: An update meta-analysis

Rui Xiong, Haitan Fu, Qianrui Zhang, Wei Li

Vol. 36

Issue 2

Pages 365-372

Published 01 Mar 2023

DOI: 10.36721/PJPS.2023.36.2.REG.365-372.1

Authors Abstract Related

Authors & Affiliations

Rui Xiong

Haitan Fu

Qianrui Zhang

Wei Li

Abstract

Our study aimed to evaluate the efficacy and toxicity of alectinib compared with crizotinib and provide

Keywords

Alectinib

Crizotinib

NSCLC

Meta-analysis

Metrics

PlumX Metrics

Safety and efficacy of alectinib versus crizotinib in alk-positive non-small cell lung cancer: An update meta-analysis

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Safety and efficacy of alectinib versus crizotinib in alk-positive non-small cell lung cancer: An update meta-analysis

Authors & Affiliations

Abstract

Keywords

Metrics